Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients.

Cunnea P, Gorgy T, Petkos K, Gowers SAN, Lu H, Morera C, Wu W, Lawton P, Nixon K, Leong CL, Sorbi F, Domenici L, Paterson A, Curry E, Gabra H, Boutelle MG, Drakakis EM, Fotopoulou C.

Sci Rep. 2018 Oct 2;8(1):14695. doi: 10.1038/s41598-018-32720-8.

2.

The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.

Antony J, Zanini E, Kelly Z, Tan TZ, Karali E, Alomary M, Jung Y, Nixon K, Cunnea P, Fotopoulou C, Paterson A, Roy-Nawathe S, Mills GB, Huang RY, Thiery JP, Gabra H, Recchi C.

EMBO Rep. 2018 Aug;19(8). pii: e45670. doi: 10.15252/embr.201745670. Epub 2018 Jun 15.

PMID:
29907679
3.

High temporal resolution delayed analysis of clinical microdialysate streams.

Gowers SAN, Hamaoui K, Cunnea P, Anastasova S, Curto VF, Vadgama P, Yang GZ, Papalois V, Drakakis EM, Fotopoulou C, Weber SG, Boutelle MG.

Analyst. 2018 Jan 29;143(3):715-724. doi: 10.1039/c7an01209h.

4.

The passive biomechanics of human pelvic collecting lymphatic vessels.

Athanasiou D, Edgar LT, Jafarnejad M, Nixon K, Duarte D, Hawkins ED, Jamalian S, Cunnea P, Lo Celso C, Kobayashi S, Fotopoulou C, Moore JE Jr.

PLoS One. 2017 Aug 21;12(8):e0183222. doi: 10.1371/journal.pone.0183222. eCollection 2017.

5.

Review article: Novel technologies in the treatment and monitoring of advanced and relapsed epithelial ovarian cancer.

Cunnea P, Gowers S, Moore JE Jr, Drakakis E, Boutelle M, Fotopoulou C.

Converg Sci Phys Oncol. 2017;3. pii: 013002. doi: 10.1088/2057-1739/aa5cf1. Epub 2017 Feb 23.

6.

Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer.

Flanagan JM, Wilson A, Koo C, Masrour N, Gallon J, Loomis E, Flower K, Wilhelm-Benartzi C, Hergovich A, Cunnea P, Gabra H, Braicu EI, Sehouli J, Darb-Esfahani S, Vanderstichele A, Vergote I, Kreuzinger C, Castillo-Tong DC, Wisman GBA, Berns EM, Siddiqui N, Paul J, Brown R.

Clin Cancer Res. 2017 May 1;23(9):2213-2222. doi: 10.1158/1078-0432.CCR-16-1754. Epub 2016 Sep 23.

7.

A method for voltage measurements of cancerous vs non-cancerous omentum.

Wu W, Vitharana K, Gorgy T, Paterson A, Cunnea P, Gabra H, Fotopoulou C, Boutelle MG, Drakakis EM.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:7514-7. doi: 10.1109/EMBC.2015.7320130.

PMID:
26738030
8.

A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.

Cheraghchi-Bashi A, Parker CA, Curry E, Salazar JF, Gungor H, Saleem A, Cunnea P, Rama N, Salinas C, Mills GB, Morris SR, Kumar R, Gabra H, Stronach EA.

Oncotarget. 2015 Dec 8;6(39):41736-49. doi: 10.18632/oncotarget.6153.

9.

The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma.

Stronach EA, Cunnea P, Turner C, Guney T, Aiyappa R, Jeyapalan S, de Sousa CH, Browne A, Magdy N, Studd JB, Sriraksa R, Gabra H, El-Bahrawy M.

Oncotarget. 2015 Oct 13;6(31):31593-603. doi: 10.18632/oncotarget.3415.

10.

Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.

Cunnea P, Stronach EA.

Front Oncol. 2014 Apr 17;4:81. doi: 10.3389/fonc.2014.00081. eCollection 2014. Review.

11.

Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis.

Cunnea P, Mháille AN, McQuaid S, Farrell M, McMahon J, FitzGerald U.

Mult Scler. 2011 Jul;17(7):808-18. doi: 10.1177/1352458511399114. Epub 2011 Mar 7.

PMID:
21382862
12.

Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.

Cunnea P, McMahon J, O'Connell E, Mashayekhi K, Fitzgerald U, McQuaid S.

Acta Neuropathol. 2010 May;119(5):601-15. doi: 10.1007/s00401-009-0618-9. Epub 2009 Dec 5.

PMID:
19967542
13.

The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis.

McQuaid S, Cunnea P, McMahon J, Fitzgerald U.

Biochem Soc Trans. 2009 Feb;37(Pt 1):329-31. doi: 10.1042/BST0370329. Review.

PMID:
19143657
14.

Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions.

Mháille AN, McQuaid S, Windebank A, Cunnea P, McMahon J, Samali A, FitzGerald U.

J Neuropathol Exp Neurol. 2008 Mar;67(3):200-11. doi: 10.1097/NEN.0b013e318165b239.

PMID:
18344911
15.

Increased expression of specific thioredoxin family proteins; a pilot immunohistochemical study on human hepatocellular carcinoma.

Cunnea P, Fernandes AP, Capitanio A, Eken S, Spyrou G, Björnstedt M.

Int J Immunopathol Pharmacol. 2007 Jan-Mar;20(1):17-24.

PMID:
17346424
16.

ERdj5, an endoplasmic reticulum (ER)-resident protein containing DnaJ and thioredoxin domains, is expressed in secretory cells or following ER stress.

Cunnea PM, Miranda-Vizuete A, Bertoli G, Simmen T, Damdimopoulos AE, Hermann S, Leinonen S, Huikko MP, Gustafsson JA, Sitia R, Spyrou G.

J Biol Chem. 2003 Jan 10;278(2):1059-66. Epub 2002 Oct 30.

Supplemental Content

Loading ...
Support Center